Publicacións en colaboración con investigadores/as de Hospital Ruber Internacional (115)

2024

  1. A new standardized nomenclature in neurosurgery: Criteria and quantitative and qualitative evaluation indicators of medical procedures

    Neurocirugia, Vol. 35, Núm. 2, pp. 95-112

  2. Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure

    Scientific Reports, Vol. 14, Núm. 1

  3. Clinical practice guideline on the management of vestibular schwannoma

    Acta Otorrinolaringologica Espanola, Vol. 75, Núm. 2, pp. 108-128

  4. Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

    eClinicalMedicine, Vol. 71

2023

  1. Esophageal biomechanics assessed by impedance planimetry (EndoFLIPTM) in healthy subjects and in patients with eosinophilic esophagitis. Normality values

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 12, pp. 693-699

  2. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

  3. Glycyrrhizinic Acid as an Antiviral and Anticancer Agent in the Treatment of Human Papillomavirus

    Journal of Personalized Medicine, Vol. 13, Núm. 12

  4. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

  5. Primary percutaneous coronary intervention in centenarians: Time to be ready

    Revista Espanola de Geriatria y Gerontologia, Vol. 58, Núm. 1, pp. 46-48

  6. Role of cortical excitatory/inhibitory imbalance in autism spectrum disorders from a symptom severity trajectories framework: a study protocol

    BMC psychiatry, Vol. 23, Núm. 1, pp. 213

  7. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

  8. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Corticospinal tract and motor cortex degeneration in pure hereditary spastic paraparesis type 4 (SPG4)

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 23, Núm. 1-2, pp. 25-34

  2. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Epilepsy and Behavior, Vol. 137

  3. Tract-specific damage at spinal cord level in pure hereditary spastic paraplegia type 4: a diffusion tensor imaging study

    Journal of Neurology, Vol. 269, Núm. 6, pp. 3189-3203

2021

  1. Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy?

    Molecular Psychiatry, Vol. 26, Núm. 1, pp. 60-65

  2. Epidaily, a scale for comprehensive functional assessment of patients with epilepsy

    Epilepsy and Behavior, Vol. 114

  3. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  4. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

  5. Management of Parkinson's disease and other movement disorders in woman of childbearing age: Part 1

    Neurologia, Vol. 36, Núm. 2, pp. 149-158